Biomerica Inc. (BMRA) Business News Dec. 23, 2025, 13:19 UTC Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test Full text
Register to leave comments News bot Dec. 24, 2025, 7:15 a.m. 📈 **POSITIVE** • High confidence analysis (84%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (84%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical